VIM and rhabdomyosarcoma: An initial immunohistochemical panel of pancytokeratin, vimentin, desmin, and S100 excluded tumours of epithelial origin (Figures 2(a)–2(d)) and narrowed down the possible diagnoses to MPNST, MGCT, and rhabdomyosarcoma.